Talphera, Inc. (TLPH)
TLPH Stock Price Chart
Explore Talphera, Inc. interactive price chart. Choose custom timeframes to analyze TLPH price movements and trends.
TLPH Company Profile
Discover essential business fundamentals and corporate details for Talphera, Inc. (TLPH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
11 Feb 2011
Employees
13.00
Website
https://talphera.comCEO
Vincent J. Angotti
Description
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. Talphera, Inc. was incorporated in 2005 and is headquartered in San Mateo, California.
TLPH Financial Timeline
Browse a chronological timeline of Talphera, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.13.
Earnings released on 14 Aug 2025
EPS came in at -$0.10 surpassing the estimated -$0.12 by +16.67%.
Earnings released on 13 May 2025
EPS came in at -$0.16 surpassing the estimated -$0.17 by +5.88%, while revenue for the quarter reached $27.00K .
Earnings released on 31 Mar 2025
EPS came in at -$0.07 surpassing the estimated -$0.21 by +66.67%.
Earnings released on 13 Nov 2024
EPS came in at -$0.13 surpassing the estimated -$0.20 by +35.00%.
Earnings released on 14 Aug 2024
EPS came in at -$0.15 surpassing the estimated -$0.22 by +31.82%.
Earnings released on 14 May 2024
EPS came in at -$0.16 surpassing the estimated -$0.28 by +42.86%.
Earnings released on 6 Dec 2023
EPS came in at -$0.08 surpassing the estimated -$0.28 by +71.43%, while revenue for the quarter reached $281.00K .
Earnings released on 8 Nov 2023
EPS came in at -$0.08 surpassing the estimated -$0.29 by +72.41%, while revenue for the quarter reached $117.00K , missing expectations by -55.51%.
Earnings released on 10 Aug 2023
EPS came in at -$0.41 surpassing the estimated -$0.53 by +22.64%, while revenue for the quarter reached $253.00K , beating expectations by +237.33%.
Earnings released on 31 Mar 2023
EPS came in at -$0.75 surpassing the estimated -$0.79 by +4.68%.
Earnings released on 31 Dec 2022
EPS came in at -$1.00 , while revenue for the quarter reached $252.00K .
Stock split effective on 26 Oct 2022
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Sept 2022
EPS came in at -$0.91 surpassing the estimated -$1.20 by +23.75%, while revenue for the quarter reached $507.00K , missing expectations by -18.88%.
Earnings released on 30 Jun 2022
EPS came in at $9.60 surpassing the estimated -$1.50 by +740.00%, while revenue for the quarter reached $570.00K , beating expectations by +3.64%.
Earnings released on 31 Mar 2022
EPS came in at -$1.19 surpassing the estimated -$1.20 by +0.73%, while revenue for the quarter reached $442.00K , missing expectations by -19.64%.
Earnings released on 31 Dec 2021
EPS came in at -$1.24 , while revenue for the quarter reached $2.00K .
Earnings released on 30 Sept 2021
EPS came in at -$1.40 , while revenue for the quarter reached $1.86M .
Earnings released on 30 Jun 2021
EPS came in at -$1.65 , while revenue for the quarter reached $443.00K .
Earnings released on 31 Mar 2021
EPS came in at -$1.58 , while revenue for the quarter reached $511.00K .
Earnings released on 31 Dec 2020
EPS came in at -$1.93 , while revenue for the quarter reached $738.00K .
Earnings released on 30 Sept 2020
EPS came in at -$2.03 , while revenue for the quarter reached $1.37M .
TLPH Stock Performance
Access detailed TLPH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.